… , stillbirth, or congenital anomalies associated with first … quinine or artesunate for the
treatment of severe malaria in first … drug exposure after receiving oral artesunate than the same …

… However, there are no specific guidelines available for the treatment of severe malaria
among neonates. We preferred parenteral artesunate over chloroquine and oral artesunate …

… P falciparum malaria with either artemether-lumefantrine or mefloquine and artesunate as …
in patients with P vivax malaria of pyronaridine-artesunate compared with chloroquine. This is …

… The mean (SD) [90% range] body weight of women in the study was 50.6 (5.8) [41–60] kg,
resulting in a mean daily dose of 200 mg oral artesunate per woman, for 3 days. Overall …

… malaria for a randomized, open-label trial with a restricted sequential trial design of 7 days
of supervised quinine (SQ7) versus 3 days of artesunate-… , or congenital abnormality rates in …

… CONCLUSIONS This study demonstrates the effects of malaria on oral ARS drug disposition
are greater than those of pregnancy. This probably results from a disease related reduction …

… falciparum malaria, but efficacy was inferior to 7 d artesunate … of artesunate which responded
to oral chlorpheniramine and … The newborn anthropometric results and neurological scores …

… There was no congenital abnormality in any of the newborn children, and the 46 children …
treated with oral artesunate in this study. The advantage of oral artesunate over intravenous …

… While data on neonatal and congenital malaria is limited, our … treatment for severe malaria
when artesunate is unavailable [… artesunate in infants, the opposite seems true for oral …

… There were 3 neonatal deaths, 2 QC7 and 1 A7, all of whom died in the first week of life
from causes unrelated to … Oral clindamycin in the treatment of acute uncomplicated falciparum …